Clinical Trial Supplies Market - Trends Forecast Till 2028

Market Overview

Global Clinical Trial Supplies market is anticipated to reach USD 2.5 billion in 2021 growing at a CAGR of 8.5% during the forecasting period, 2021-2028.

Clinical trial supplies include the supply of material and devices that are essentially need to perform a clinical trial. These include 24-hour collection and delivery of biological specimens, investigational drugs, kits and other study materials. A clinical supply chain is the process of manufacturing and distributing the end product from the raw material. Other supplies used in the clinical trial are termed as Non medical supply and include cleaning supply, pharmacy supply etc.

With an increased R&D in the sector along with increased clinical trials are some of the factors that have supported long-term expansion for Clinical Trial Supplies industry.

Key Findings

Global Clinical Trial Supplies market is segmented into Services, Phase, Type, Therapeutic Areas and geography.

Services segment is segmented into Manufacturing, Packaging, Logistics, and Distribution

Phase segment is segmented into I to IV

Type segment is segmented into Small molecule, Biologics, Medical Devices

Therapeutic areas segment is segmented into Oncology, CNS, CVD, Infectious, Immunology

Geographically, global Clinical Trial Supplies market is sub segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions

Competitive Landscape

Key players in global Clinical Trial Supplies market are Thermo Fisher (US), Catalent, Inc. (US), Parexel (US), Eurofins (France) UDG Healthcare (Ireland), Piramal Pharma Solutions (India), Almac Group (UK), PCI Pharma Services (US), PRA Health Sciences (US), Biocair (UK), Eurofins (France), Marken (US), Infosys (India), Liveo Research (India), Capsugel (a Lonza Group company) (Switzerland), SIRO Clinpharm (India), KLIFO A/S (Denmark), Clinigen (UK), Ancillare (US), N-SIDE (Belgium), ADAllen (UK), Rubicon (India), Durbin (UK), Recipharm (Sweden), Seveillar (India), Myonex (India) among others.

Reasons to Acquire

• Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
• Gain authentic and granular data access for Clinical Trial Supplies market so as to understand the trends and the factors involved behind changing market situations
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope